Literature DB >> 23652747

Fecal lactoferrin: a noninvasive fecal biomarker for the diagnosis and surveillance of pouchitis.

S Gonsalves1, M Lim, P Finan, P Sagar, D Burke.   

Abstract

BACKGROUND: Fecal lactoferrin is a marker of intestinal inflammation and can be assessed with a simple qualitative immunochromatographic rapid test.
OBJECTIVE: We aimed to assess the sensitivity and specificity of the test in the diagnosis of pouchitis and evaluate its clinical utility in the surveillance of inflammation of the pouch after antibiotic therapy.
DESIGN: Between October 2005 and September 2009, we recruited a consecutive series of patients who had their ileal pouch examined under a general anesthetic. Distinctions between healthy and inflamed pouches were made by the use of the Pouch Disease Activity Index. Fecal samples were taken before biopsy of the pouch, and a clinician blinded to the examination findings performed the lactoferrin test. After antimicrobial treatment, a number of patients with pouchitis had a repeat examination and lactoferrin test.
RESULTS: There were 85 (41 male) patients. Median age was 42 (interquartile range, 36-49) years. Twenty-four patients had pouchitis. The test was positive in all 24 patients with pouchitis and 5 patients with a healthy pouch. The sensitivity and specificity of the test for pouchitis was 100% and 92%. The positive predictive value was 82%. In 7 patients who received antibiotic treatment for their pouchitis, the test was able to accurately predict the resolution and/or persistence of pouchitis.
CONCLUSION: The qualitative fecal lactoferrin rapid test is a sensitive method for the diagnosis and confirmation of resolution of pouchitis. The test provides clinicians with greater confidence in the prescription of antibiotics for suspected pouchitis and its surveillance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652747     DOI: 10.1097/DCR.0b013e318280194a

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

1.  Update on the pathogenesis and management of pouchitis.

Authors:  Saleem Chowdhry; Jeffry A Katz
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

2.  Noninvasive Markers of Disease Activity in Inflammatory Bowel Disease.

Authors:  Raluca Vrabie; Sunanda Kane
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-09

Review 3.  Disease Monitoring of the Ileoanal Pouch: How to Utilize Biomarkers, Imaging, and Pouchoscopy.

Authors:  Edward L Barnes; Kimberly Darlington; Hans H Herfarth
Journal:  Curr Gastroenterol Rep       Date:  2022-10-18

4.  Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States.

Authors:  Edward L Barnes; Laura Raffals; Millie D Long; Gaurav Syal; Maia Kayal; Ashwin Ananthakrishnan; Benjamin Cohen; Joel Pekow; Parakkal Deepak; Jean-Frederic Colombel; Hans H Herfarth; Robert S Sandler
Journal:  Crohns Colitis 360       Date:  2020-07-24

5.  Consecutive Monitoring of Fecal Calprotectin and Lactoferrin for the Early Diagnosis and Prediction of Pouchitis after Restorative Proctocolectomy for Ulcerative Colitis.

Authors:  Takayuki Yamamoto; Takahiro Shimoyama; Takuya Bamba; Koichi Matsumoto
Journal:  Am J Gastroenterol       Date:  2015-04-28       Impact factor: 10.864

6.  Disease Activity Indices for Pouchitis: A Systematic Review.

Authors:  Rocio Sedano; Tran M Nguyen; Ahmed Almradi; Florian Rieder; Claire E Parker; Lisa M Shackelton; Geert D'Haens; William J Sandborn; Brian G Feagan; Christopher Ma; Vipul Jairath
Journal:  Inflamm Bowel Dis       Date:  2022-03-30       Impact factor: 7.290

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.